Company profilePharmaceutical#307 of 1,318 in Pakistan✓ No DRAP alerts

ORTA LABS. (PVT) LTD.

Pharmaceutical company · 57 brands · 64 molecules

Ranked #13 of 60 companies in Antithrombotic Agents

57 registered products 27 pharmaceutical brands 64 distinct molecules 0 DRAP alerts

Company overview

57
registered products
27
pharmaceutical brands
64
distinct molecules
10
therapeutic classes
0
DRAP alerts

ORTA LABS. (PVT) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 57 product registrations across 64 distinct molecules. Its portfolio is concentrated in Antithrombotic Agents and Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord). It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by ORTA

1 product matched in our catalogue — each with its observed price and DRAP approved ceiling.

Top molecules by brand count

Diclofenac3 brands
Pyridoxine3 brands
Thiamine3 brands
Amikacin2 brands
Azithromycin2 brands
Folic Acid2 brands
Fexofenadine2 brands
Aspirin2 brands

Therapeutic classes

Antithrombotic Agents · 3Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 3Antianemic, Iron Preparations · 2Antiemetics & Antinauseants · 2Aminoglycoside Antibacterials · 1Angiotensin-Ii Antagonists, Combinations · 1Vitamin B12 Plain · 1Drugs For Constipation · 1Lipid Modifying Agents · 1Blood Glucose Lowering Drugs, Excluding Insulin · 1

Price band (DRAP official ceilings)

Registered products priced by source
DVAGO1 products · Rs 185 – Rs 185
Median across source: Rs 185

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Wilshire Laboratories (Private) Limited holds 132 molecules not in this portfolio
AcyclovirAcyclovir SodiumAlfacalcidolAmlodipineAmoxicillinAmoxycillin
Albro Pharmaceuticals holds 21 molecules not in this portfolio
AdapaleneAdapleneBetamethasoneClindamycinClioquinolDesloratadine
SEARLE PAKISTAN (PVT.) LTD. holds 237 molecules not in this portfolio
AcetazolamideAdalimumabAlprazolamAmilorideAminophyllineAmitriptyline

Get the full profile for ORTA

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.